Letrozole

Letrozole

By Roxane Laboratories, Inc. | Last revised: 3 June 2011

Letrozole Tablets USP are an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1). Extended adjuvant treatment of postmenopausal women with early breast cancer who…

Letrozole

Letrozole

By Kremers Urban Pharmaceuticals Inc. | Last revised: 1 February 2011

Letrozole is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1) Extended adjuvant treatment of postmenopausal women with early breast cancer who have received…

LETROZOLE

LETROZOLE

By Breckenridge Pharmaceutical, Inc. | Last revised: 7 June 2011

Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1). Extended adjuvant treatment of postmenopausal women with early breast cancer who have…

LETROZOLE

LETROZOLE

By INDICUS PHARMA LLC | Last revised: 7 July 2011

Letrozole tablets are an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1) Extended adjuvant treatment of postmenopausal women with early breast cancer who have…

Letrozole

LETROZOLE

By Qualitest Pharmaceuticals | Last revised: 8 March 2012

Letrozole Tablets USP is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1) Extended adjuvant treatment of postmenopausal women with early breast cancer who have…